Mucosal immune tolerance at the ocular surface in health and disease

Immunology

Volumn 150, Issue 4, 2017, Pages 397-407

  Galletti, Jeremías G ^a   Guzmán, Mauricio ^a   Giordano, Mirta N ^a  

^a ACADEMIA NACIONAL DE MEDICINA   (Argentina)

Author keywords

Allergic conjunctivitis; Conjunctival inflammation; Dry eye; Mucosal tolerance; Ocular mucosal immune system; Ocular surface

Indexed keywords

EYE DROPS; PRESERVATIVE; ALLERGEN; IRRITANT AGENT;

ALLERGIC REACTION; CONJUNCTIVA; CORNEA; CORNEA LIMBUS; DRY EYE; EYE; EYE ALLERGY; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; INFORMATION; MEDLINE; MUCOSA; OCULAR ALLERGY; OCULAR SURFACE DISEASE; PRIORITY JOURNAL; REVIEW; TEAR FILM; TOXICITY; ANIMAL; EYE DISEASE; IMMUNOLOGY; INFLAMMATION; MUCOSAL IMMUNITY;

ALLERGENS; ANIMALS; EYE; EYE DISEASES; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; INFLAMMATION; IRRITANTS;

EID: 85013459373     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12716     Document Type: Review

References (129)

1. Sheng X-L, Li H-P, Liu Q-X, Rong W-N, Du W-Z, Ma L et al. Prevalence and associated factors of corneal blindness in Ningxia in northwest China. Int J Ophthalmol 2014; 7:557-62.
2. Niederkorn JY, Larkin DFP. Immune privilege of corneal allografts. Ocul Immunol Inflamm 2010; 18:162-71.
3. McDermott AM. Antimicrobial compounds in tears. Exp Eye Res 2013; 117:53-61.
4. Mantelli F, Mauris J, Argüeso P. The ocular surface epithelial barrier and other mechanisms of mucosal protection: from allergy to infectious diseases. Curr Opin Allergy Clin Immunol 2013; 13:563-8.
5. Ueta M, Kinoshita S. Ocular surface inflammation is regulated by innate immunity. Prog Retin Eye Res 2012; 31:551-75.
6. McCauley HA, Guasch G. Three cheers for the goblet cell: maintaining homeostasis in mucosal epithelia. Trends Mol Med 2015; 21:492-503.
7. Agnifili L, Mastropasqua R, Fasanella V, Di Staso S, Mastropasqua A, Brescia L et al. In vivo confocal microscopy of conjunctiva-associated lymphoid tissue in healthy humans. Invest Ophthalmol Vis Sci 2014; 55:5254-62.
8. Pabst O, Mowat AM. Oral tolerance to food protein. Mucosal Immunol 2012; 5:232-9.
9. Swamy M, Jamora C, Havran W, Hayday A. Epithelial decision makers: in search of the “epimmunome”. Nat Immunol 2010; 11:656-65.
10. Goto Y, Ivanov II. Intestinal epithelial cells as mediators of the commensal-host immune crosstalk. Immunol Cell Biol 2013; 91:204-14.
11. Papazian D, Hansen S, Würtzen PA. Airway responses towards allergens-from the airway epithelium to T cells. Clin Exp Allergy 2015; 45:1268-87.
12. Rescigno M. Dendritic cell-epithelial cell crosstalk in the gut. Immunol Rev 2014; 260:118-28.
13. Lambrecht BN, Hammad H. Dendritic cell and epithelial cell interactions at the origin of murine asthma. Ann Am Thorac Soc 2014; 11(Suppl 5):S236-43.
14. Aliberti J. Immunity and tolerance induced by intestinal mucosal dendritic cells. Mediators Inflamm 2016; 2016:3104727.
15. Hintzen G, Ohl L, del Rio M-L, Rodriguez-Barbosa J-I, Pabst O, Kocks JR et al. Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node. J Immunol 2006; 177:7346-54.
16. Baratin M, Foray C, Demaria O, Habbeddine M, Pollet E, Maurizio J et al. Homeostatic NF-jB signaling in steady-state migratory dendritic cells regulates immune homeostasis and tolerance. Immunity 2015; 42:627-39.
17. Shan M, Gentile M, Yeiser JR, Walland AC, Bornstein VU, Chen K et al. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science 2013; 342:447-53.
18. +dendritic cells in the small intestine. Nature 2012; 483:345-9.
19. Arce-Sillas A, Álvarez-Luqúın DD, Tamaya-Domíınguez B, Gomez-Fuentes S, Trejo-García A, Melo-Salas M et al. Regulatory T cells: molecular actions on effector cells in immune regulation. J Immunol Res 2016; 2016:1720827.
20. Zhang H, Kong H, Zeng X, Guo L, Sun X, He S. Subsets of regulatory T cells and their roles in allergy. J Transl Med 2014; 12:125.
21. Menon BB, Kaiser-Marko C, Spurr-Michaud S, Tisdale AS, Gipson IK. Suppression of Toll-like receptor-mediated innate immune responses at the ocular surface by the membrane-associated mucins MUC 1 and MUC16. Mucosal Immunol 2015; 8:1000-8.
22. Bauskar A, Mack WJ, Mauris J, Argüeso P, Heur M, Nagel BA et al. Clusterin seals the ocular surface barrier in mouse dry eye. PLoS ONE 2015; 10:e0138958.
23. Mun JJ, Tam C, Evans DJ, Fleiszig SMJ. Modulation of epithelial immunity by mucosal fluid. Sci Rep 2011; 1:8.
24. Wullaert A, Bonnet MC, Pasparakis M. NF-jB in the regulation of epithelial homeostasis and inflammation. Cell Res 2011; 21:146-58.
25. Pasparakis M. Role of NF-jB in epithelial biology. Immunol Rev 2012; 246:346-58.
26. Redfern RL, Reins RY, McDermott AM. Toll-like receptor activation modulates antimicrobial peptide expression by ocular surface cells. Exp Eye Res 2011; 92:209-20.
27. Li J, Setiawan M, Wu H, Beuerman RW, Zhao P. Regulation of Toll-like receptor expression in human conjunctival epithelial cells. Mediators Inflamm 2014; 2014:493596.
28. Simmons KT, Xiao Y, Pflugfelder SC, de Paiva CS. Inflammatory response to lipopolysaccharide on the ocular surface in a murine dry eye model. Invest Ophthalmol Vis Sci 2016; 57:2443-51.
29. McGilligan VE, Gregory-Ksander MS, Li D, Moore JE, Hodges RR, Gilmore MS et al. Staphylococcus aureus activates the NLRP 3 inflammasome in human and rat conjunctival goblet cells. PLoS ONE 2013; 8:e74010.
30. Zheng X, Ma P, de Paiva CS, Cunningham MA, Hwang CS, Pflugfelder SC et al. TSLP and downstream molecules in experimental mouse allergic conjunctivitis. Invest Ophthalmol Vis Sci 2010; 51:3076-82.
31. Deng R, Su Z, Lu F, Zhang L, Lin J, Zhang X et al. A potential link between bacterial pathogens and allergic conjunctivitis by dendritic cells. Exp Eye Res 2014; 120:118-26.
32. Contreras-Ruiz L, Masli S. Immunomodulatory cross-talk between conjunctival goblet cells and dendritic cells. PLoS ONE 2015; 10:e0120284.
33. El Annan J, Goyal S, Zhang Q, Freeman GJ, Sharpe AH, Dana R. Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation. Investig Opthalmology Vis Sci 2010; 51:3418.
34. Ferrari G, Hajrasouliha AR, Sadrai Z, Ueno H, Chauhan SK, Dana R. Nerves and neovessels inhibit each other in the cornea. Invest Ophthalmol Vis Sci 2013; 54:813-20.
35. Dohlman TH, Chauhan SK, Kodati S, Hua J, Chen Y, Omoto M et al. The CCR6/ CCL 20 axis mediates Th 17 cell migration to the ocular surface in dry eye disease. Invest Ophthalmol Vis Sci 2013; 54:4081-91.
36. Coursey TG, Bohat R, Barbosa FL, Pflugfelder SC, de Paiva CS. Desiccating stressinduced chemokine expression in the epithelium is dependent on upregulation of NKG2D/RAE-1 and release of IFN-c in experimental dry eye. J Immunol 2014; 193:5264-72.
37. Forrester JV, Xu H, Kuffová L, Dick AD, McMenamin PG. Dendritic cell physiology and function in the eye. Immunol Rev 2010; 234:282-304.
38. Rodrigues MM, Rowden G, Hackett J, Bakos I. Langerhans cells in the normal conjunctiva and peripheral cornea of selected species. Invest Ophthalmol Vis Sci 1981; 21:759-65.
39. Efron N, Al-Dossari M, Pritchard N. In vivo confocal microscopy of the bulbar conjunctiva. Clin Experiment Ophthalmol 2009; 37:335-44.
40. Hattori T, Chauhan SK, Lee H, Ueno H, Dana R, Kaplan DH et al. Characterization of Langerin-expressing dendritic cell subsets in the normal cornea. Invest Ophthalmol Vis Sci 2011; 52:4598-604.
41. +mouse dendritic cells under normal conditions and in allergic immune responses. Kovats S, editor. PLoS ONE 2013; 8:e64193.
42. Ohbayashi M, Manzouri B, Flynn T, Toda M, Ikeda Y, Nakamura T et al. Dynamic changes in conjunctival dendritic cell numbers, anatomical position and phenotype during experimental allergic conjunctivitis. Exp Mol Pathol 2007; 83:216-23.
43. Nakano H, Free ME, Whitehead GS, Maruoka S, Wilson RH, Nakano K et al. Pulmonary CD103+ dendritic cells prime Th2 responses to inhaled allergens. Mucosal Immunol 2012; 5:53-65.
44. Yamagami S, Yokoo S, Usui T, Yamagami H, Amano S, Ebihara N. Distinct populations of dendritic cells in the normal human donor corneal epithelium. Invest Ophthalmol Vis Sci 2005; 46:4489-94.
45. Lee EJ, Rosenbaum JT, Planck SR. Epifluorescence intravital microscopy of murine corneal dendritic cells. Invest Ophthalmol Vis Sci 2010; 51:2101-8.
46. Hamrah P, Zhang Q, Liu Y, Dana MR. Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest Ophthalmol Vis Sci 2002; 43:639-46.
47. Zhang X, Volpe EA, Gandhi NB, Schaumburg CS, Siemasko KF, Pangelinan SB et al. NK cells promote Th-17 mediated corneal barrier disruption in dry eye. PLoS ONE 2012; 7:e36822.
48. Hingorani M, Metz D, Lightman SL. Characterisation of the normal conjunctival leukocyte population. Exp Eye Res 1997; 64:905-12.
49. +cells regulate the T helper-17 response in an experimental murine model of Sjögren syndrome. Mucosal Immunol 2014; 7:417-27.
50. +regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation. Invest Ophthalmol Vis Sci 2008; 49:5434-40.
51. Sack RA, Beaton A, Sathe S, Morris C, Willcox M, Bogart B. Towards a closed eye model of the pre-ocular tear layer. Prog Retin Eye Res 2000; 19:649-68.
52. Tan KO, Sack RA, Holden BA, Swarbrick HA. Temporal sequence of changes in tear film composition during sleep. Curr Eye Res 1993; 12:1001-7.
53. Yamamoto K, Ladage PM, Ren DH, Li L, Petroll WM, Jester JV et al. Effect of eyelid closure and overnight contact lens wear on viability of surface epithelial cells in rabbit cornea. Cornea 2002; 21:85-90.
54. Prabhasawat P, Tseng SC. Frequent association of delayed tear clearance in ocular irritation. Br J Ophthalmol 1998; 82:666-75.
55. de Paiva CS, Pflugfelder SC. Tear clearance implications for ocular surface health. Exp Eye Res 2004; 78:395-7.
56. Dua HS, Donoso LA, Laibson PR. Conjunctival instillation of retinal antigens induces tolerance. Does it invoke mucosal tolerance mediated via conjunctiva associated lymphoid tissues (CALT)? Ocul Immunol Inflamm 1994; 2:29-36.
57. Egan RM, Yorkey C, Black R, Loh WK, Stevens JL, Storozynsky E et al. In vivo behavior of peptide-specific T cells during mucosal tolerance induction: antigen introduced through the mucosa of the conjunctiva elicits prolonged antigen-specific T cell priming followed by anergy. J Immunol 2000; 164:4543-50.
58. Mowat AM, Strobel S, Drummond HE, Ferguson A. Immunological responses to fed protein antigens in mice. I. Reversal of oral tolerance to ovalbumin by cyclophosphamide. Immunology 1982; 45:105-13.
59. Wolvers DA, Coenen-de Roo CJ, Mebius RE, van der Cammen MJ, Tirion F, Miltenburg AM et al. Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: studies with OVA and human cartilage gp-39. J Immunol 1999; 162:1994-8.
60. +T-cell responses induced following topical ocular or intranasal immunization. Clin Vaccine Immunol 2010; 17:342-53.
61. Worbs T, Bode U, Yan S, Hoffmann MW, Hintzen G, Bernhardt G et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J Exp Med 2006; 203:519-27.
62. Kodati S, Chauhan SK, Chen Y, Dohlman TH, Karimian P, Saban D et al. CCR7 is critical for the induction and maintenance of Th17 immunity in dry eye disease. Invest Ophthalmol Vis Sci 2014; 55:5871-7.
63. Hämäläinen KM, Kananen K, Auriola S, Kontturi K, Urtti A. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. Invest Ophthalmol Vis Sci 1997; 38:627-34.
64. Dang Z, Kuffová L, Liu L, Forrester JV. Soluble antigen traffics rapidly and selectively from the corneal surface to the eye draining lymph node and activates T cells when codelivered with CpG oligonucleotides. J Leukoc Biol 2014; 95:431-40.
65. Smith KM, Davidson JM, Garside P. T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division. Immunology 2002; 106:144-58.
66. Gütgemann I, Fahrer AM, Altman JD, Davis MM, Chien YH. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity 1998; 8:667-73.
67. Ciabattini A, Pettini E, Fiorino F, Prota G, Pozzi G, Medaglini D. Distribution of primed T cells and antigen-loaded antigen presenting cells following intranasal immunization in mice. Zimmer J, editor. PLoS ONE 2011; 6:e19346.
68. Azimi M, Aslani S, Mortezagholi S, Salek A, Javan MR, Rezaiemanesh A et al. Identification, isolation, and functional assay of regulatory T cells. Immunol Invest 2016; 45:584-602.
69. Friedman A, Weiner HL. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 1994; 91:6688-92.
70. Galletti JG, Gabelloni ML, Morande PE, Sabbione F, Vermeulen ME, Trevani AS et al. Benzalkonium chloride breaks down conjunctival immunological tolerance in a murine model. Mucosal Immunol 2013; 6:24-34.
71. Guzmán M, Keitelman I, Sabbione F, Trevani AS, Giordano MN, Galletti JG. Desiccating stress-induced disruption of ocular surface immune tolerance drives dry eye disease. Clin Exp Immunol 2016; 184:248-56.
72. Guzmán M, Keitelman I, Sabbione F, Trevani AS, Giordano MN, Galletti JG. Mucosal tolerance disruption favors disease progression in an extraorbital lacrimal gland excision model of murine dry eye. Exp Eye Res 2016; 151:19-22.
73. Pellerin L, Jenks JA, Bégin P, Bacchetta R, Nadeau KC. Regulatory T cells and their roles in immune dysregulation and allergy. Immunol Res 2014; 58:358-68.
74. Stern ME, Schaumburg CS, Pflugfelder SC. Dry eye as a mucosal autoimmune disease. Int Rev Immunol 2013; 32:19-41.
75. Niederkorn JY, Stern ME, Pflugfelder SC, De Paiva CS, Corrales RM, Gao J et al. Desiccating stress induces T cell-mediated Sjögren’s syndrome-like lacrimal keratoconjunctivitis. J Immunol 2006; 176:3950-7.
76. Chauhan SK, El Annan J, Ecoiffier T, Goyal S, Zhang Q, Saban DR et al. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol 2009; 182:1247-52.
77. Chen Y, Chauhan SK, Lee HS, Saban DR, Dana R. Chronic dry eye disease is principally mediated by effector memory Th17 cells. Mucosal Immunol 2014; 7:38-45.
78. Stern ME, Schaumburg CS, Siemasko KF, Gao J, Wheeler LA, Grupe DA et al. Autoantibodies contribute to the immunopathogenesis of experimental dry eye disease. Invest Ophthalmol Vis Sci 2012; 53:2062-75.
79. Ostanin DV, Bao J, Koboziev I, Gray L, Robinson-Jackson SA, Kosloski-Davidson M et al. T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol 2009; 296:G135-46.
80. Landers CJ, Cohavy O, Misra R, Yang H, Lin Y, Braun J et al. Selected loss of tolerance evidenced by Crohn’s disease-associated immune responses to auto-and microbial antigens. Gastroenterology 2002; 123:689-99.
81. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998; 66:5224-31.
82. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY et al. Hostmicrobe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491:119-24.
83. Matsuoka K, Kanai T. The gut microbiota and inflammatory bowel disease. Semin Immunopathol 2015; 37:47-55.
84. Baudouin C, Aragona P, Messmer EM, Tomlinson A, Calonge M, Boboridis KG et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf 2013; 11:246-58.
85. Alex A, Edwards A, Hays JD, Kerkstra M, Shih A, de Paiva CS et al. Factors predicting the ocular surface response to desiccating environmental stress. Invest Ophthalmol Vis Sci 2013; 54:3325-32.
86. Chen Y, Chauhan SK, Saban DR, Sadrai Z, Okanobo A, Dana R. Interferon-γ-secreting NK cells promote induction of dry eye disease. J Leukoc Biol 2011; 89:965-72.
87. Li D-Q, Luo L, Chen Z, Kim H-S, Song XJ, Pflugfelder SC. JNK and ERK MAP kinases mediate induction of IL-1b, TNF-a and IL-8 following hyperosmolar stress in human limbal epithelial cells. Exp Eye Res 2006; 82:588-96.
88. Li D-Q, Chen Z, Song XJ, Luo L, Pflugfelder SC. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2004; 45:4302-11.
89. Pflugfelder SC, Farley W, Luo L, Chen LZ, de Paiva CS, Olmos LC et al. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am J Pathol 2005; 166:61-71.
90. Zhang X, Chen W, De Paiva CS, Corrales RM, Volpe EA, McClellan AJ et al. Interferon-c exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways. Investig Opthalmology Vis Sci 2011; 52:6279.
91. Willcox MDP. Characterization of the normal microbiota of the ocular surface. Exp Eye Res 2013; 117:99-105.
92. Zegans ME, Van Gelder RN. Considerations in understanding the ocular surface microbiome. Am J Ophthalmol 2014; 158:420-2.
93. Reyes NJ, Saban DR. T helper subsets in allergic eye disease. Curr Opin Allergy Clin Immunol 2014; 14:477-84.
94. Gomes PJ. Trends in prevalence and treatment of ocular allergy. Curr Opin Allergy Clin Immunol 2014; 14:451-6.
95. Berra M, Galperín G, Dawidowski L, Tau J, Márquez I, Berra A. Impact of wildfire smoke in Buenos Aires, Argentina, on ocular surface. Arq Bras Oftalmol 2015; 78:110-4.
96. Guarnieri M, Balmes JR. Outdoor air pollution and asthma. Lancet 2014; 383:1581-92.
97. Tau J, Novaes P, Matsuda M, Tasat DR, Saldiva PH, Berra A. Diesel exhaust particles selectively induce both proinflammatory cytokines and mucin production in cornea and conjunctiva human cell lines. Invest Ophthalmol Vis Sci 2013; 54:4759-65.
98. Fujishima H, Satake Y, Okada N, Kawashima S, Matsumoto K, Saito H et al. Effects of diesel exhaust particles on primary cultured healthy human conjunctival epithelium. Ann Allergy Asthma Immunol 2013; 110:39-43.
99. Lasagni Vitar RM, Tau J, Reides CG, Berra A, Ferreira SM, Llesuy SF. Evaluation of oxidative stress markers in human conjunctival epithelial cells exposed to diesel exhaust particles (DEP). Invest Ophthalmol Vis Sci 2015; 56:7058-66.
100. Rummenie VT, Matsumoto Y, Dogru M, Wang Y, Hu Y, Ward SK et al. Tear cytokine and ocular surface alterations following brief passive cigarette smoke exposure. Cytokine 2008; 43:200-8.
101. Robays LJ, Lanckacker EA, Moerloose KB, Maes T, Bracke KR, Brusselle GG et al. Concomitant inhalation of cigarette smoke and aerosolized protein activates airway dendritic cells and induces allergic airway inflammation in a TLR-independent way. J Immunol 2009; 183:2758-66.
102. Moerloose KB, Robays LJ, Maes T, Brusselle GG, Tournoy KG, Joos GF. Cigarette smoke exposure facilitates allergic sensitization in mice. Respir Res 2006; 7:49.
103. Matsumoto Y, Dogru M, Goto E, Sasaki Y, Inoue H, Saito I et al. Alterations of the tear film and ocular surface health in chronic smokers. Eye (Lond) 2008; 22:961-8.
104. Thomas J, Jacob GP, Abraham L, Noushad B. The effect of smoking on the ocular surface and the precorneal tear film. Australas Med J 2012; 5:221-6.
105. Seo KY, Han SJ, Cha H-R, Seo S-U, Song J-H, Chung S-H et al. Eye mucosa: an efficient vaccine delivery route for inducing protective immunity. J Immunol 2010; 185:3610-9.
106. Fukuda K, Ishida W, Harada Y, Wakasa Y, Takagi H, Takaiwa F et al. Prevention of allergic conjunctivitis in mice by a rice-based edible vaccine containing modified Japanese cedar pollen allergens. Br J Ophthalmol 2015; 99:705-9.
107. Guzmán M, Sabbione F, Gabelloni ML, Vanzulli S, Trevani AS, Giordano MN et al. Restoring conjunctival tolerance by topical nuclear factor-κB inhibitors reduces preservative-facilitated allergic conjunctivitis in mice. Invest Ophthalmol Vis Sci 2014; 55:6116-26.
108. Ye Y-L, Chuang Y-H, Chiang B-L. Strategies of mucosal immunotherapy for allergic diseases. Cell Mol Immunol 2011; 8:453-61.
109. Nye M, Rudner S, Bielory L. Emerging therapies in allergic conjunctivitis and dry eye syndrome. Expert Opin Pharmacother 2013; 14:1449-65.
110. Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 2010; 29:312-34.
111. De Saint Jean M. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci 1999; 40:619-30.
112. Massingale ML, Li X, Vallabhajosyula M, Chen D, Wei Y, Asbell PA. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea 2009; 28:1023-7.
113. Zhou Y. Modulation of the canonical Wnt pathway by benzalkonium chloride in corneal epithelium. Exp Eye Res 2011; 93:355-62.
114. Di Girolamo N, Coroneo MT, Wakefield D. UVB-elicited induction of MMP-1 expression in human ocular surface epithelial cells is mediated through the ERK1/2 MAPKdependent pathway. Invest Ophthalmol Vis Sci 2003; 44:4705-14.
115. Luo L, Li D-Q, Doshi A, Farley WJ, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 2004; 45:4293-301.
116. Kim H-S, Luo L, Pflugfelder SC, Li D-Q. Doxycycline inhibits TGF-β1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2005; 46:840-8.
117. Luo L, Li D-Q, Corrales RM, Pflugfelder SC. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens 2005; 31:186-93.
118. Lan W, Petznick A, Heryati S, Rifada M, Tong L. Nuclear factor-κB: central regulator in ocular surface inflammation and diseases. Ocul Surf 2012; 10:137-48.
119. Li D-Q, Zhou N, Zhang L, Ma P, Pflugfelder SC. Suppressive effects of azithromycin on zymosan-induced production of proinflammatory mediators by human corneal epithelial cells. Invest Ophthalmol Vis Sci 2010; 51:5623-9.
120. Kashkouli MB, Fazel AJ, Kiavash V, Nojomi M, Ghiasian L. Oral azithromycin versus doxycycline in meibomian gland dysfunction: a randomised double-masked open-label clinical trial. Br J Ophthalmol 2015; 99:199-204.
121. Saika S, Miyamoto T, Yamanaka O, Kato T, Ohnishi Y, Flanders KC et al. Therapeutic effect of topical administration of SN50, an inhibitor of nuclear factor-κB, in treatment of corneal alkali burns in mice. Am J Pathol 2005; 166:1393-403.
122. Conway TF, Hammer L, Furtado S, Mathiowitz E, Nicoletti F, Mangano K et al. Oral delivery of particulate transforming growth factor β1 and all-trans retinoic acid reduces gut inflammation in murine models of inflammatory bowel disease. J Crohns Colitis 2015; 9:647-58.
123. De Paiva CS, Volpe EA, Gandhi NB, Zhang X, Zheng X, Pitcher JD et al. Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca. PLoS ONE 2011; 6:e29017.
124. Desreumaux P, Foussat A, Allez M, Beaugerie L, Hébuterne X, Bouhnik Y et al. Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn’s disease. Gastroenterology 2012; 143:1207-17-2.
125. Navarro S, Lazzari A, Kanda A, Fleury S, Dombrowicz D, Glaichenhaus N et al. Bystander immunotherapy as a strategy to control allergen-driven airway inflammation. Mucosal Immunol 2015; 8:841-51.
126. +T cell mediated ocular surface disease in experimental dry eye disease. PLoS ONE 2013; 8:e78508.
127. Daubeuf F, Jung F, Douglas GJ, Chevalier E, Frossard N. Protective effect of a Protein Epitope Mimetic CCR 10 antagonist, POL7085, in a model of allergic eosinophilic airway inflammation. Respir Res 2015; 16:77.
128. Kugadas A, Gadjeva M. Impact of microbiome on ocular health. Ocul Surf 2016; 14:342-9.
129. de Paiva CS, Jones DB, Stern ME, Bian F, Moore QL, Corbiere S et al. Altered mucosal microbiome diversity and disease severity in Sjögren syndrome. Sci Rep 2016; 6:23561.